UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000011210 |
|---|---|
| Receipt number | R000013140 |
| Scientific Title | Randomized Phase II trial on conventional administration (continuous administration for 2 weeks followed by one week interval) and alternate-day administration of adjuvant chemotherapy drug TS-1 in patients who underwent complete resection of non-small cell lung cancer. |
| Date of disclosure of the study information | 2013/08/01 |
| Last modified on | 2023/01/23 10:09:31 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/07/17 15:32:43 | ||
| 2 | Update | 2013/09/02 12:21:06 | Recruitment status |
|
| 3 | Update | 2013/11/12 19:06:37 | Email TEL Co-sponsor Co-sponsor |
|
| 4 | Update | 2014/02/18 14:28:41 | Email Co-sponsor |
|
| 5 | Update | 2014/02/18 15:06:22 | Email Email1 |
|
| 6 | Update | 2015/01/17 14:27:52 | Key inclusion criteria |
|
| 7 | Update | 2016/02/29 10:49:30 | Email1 |
|
| 8 | Update | 2018/03/01 09:49:14 | Recruitment status |
|
| 9 | Update | 2023/01/23 10:09:31 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of primary person or sponsor Organization Tel1 Organization Organization Address Address Tel |
